
Oncology online community. Dedicated to sharing experience and best practices. #oncology #MedTwitter
Joined July 2020
- Tweets162
- Following1.1K
- Followers696
- Likes203
The Oncologist Community retweeted
Molecular classification of renal cancer (7 groups). 1+2=angiogenesis (PBRM1 rich). 3+4 = immune and cell cycle rich. Group 5 +6 proliferative (p53 CDK2NA) = new therapies needed . Personalised randomised trials are possible.
The Oncologist Community retweeted
#SARSCoV2_Vaccines in Development | Mucosal and Systemic Responses | Florian Krammer @IcahnMountSinai @Nature buff.ly/2S9IScA | #2020_ReCapOct
The Oncologist Community retweeted
1) Only for t(11;14), consider + PI
2) A t(11;14) at diagnosis should be canonical - if (-) at relapse, ven should act similarly.
3) Consider an azole & halve the dose of ven.
4) Be ready for a rapid response (weeks)
5) Responses wane (~1 year) - what's the next step? #mmsm
The Oncologist Community retweeted
Final results of KROG0806: IMNI in node positive BC (presented by @hkbyun_ at 2020 KOSRO). First rad_onc multicenter ph3 RCT in Korea. So proud of Chang-ok Suh (PI) and Yong Bae Kim, my mentors for conducting this trial for 12 years from scratch. 👍👏🙏
The Oncologist Community retweeted
ENHERTU/Trastuzumab deruxtecan Granted Priority Review in the U.S. for Treatment of HER2 Positive Metastatic Gastric Cancer. Good to have more treatment options ! #stomachcancer #FDA daiichisankyo.com/media/pres…
4 months after ASCO and NEJM publication, Trastuzumab deruxtecan is approved for HER2 positive gastric cancer in Japan. Great news for us and our patients. I really appreciate all participants for the trial. daiichisankyo.com/media_inve…
#gastric #cancer #HER2 #Trastuzumab #ASCO #ADC
The Oncologist Community retweeted
🚨⭐️Just in👉Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies @myESMO @ESMO_Open @notahedge esmoopen.bmj.com/content/5/5…
The Oncologist Community retweeted
Adding radiotherapy to immunotherapy improves OS and doubles out-of-field "abscopal" responses in #NSCLC. https://xitter.gq/t.co/Aka79WnNja. Our tumor agnostic Belgian CHEERS-trial (https://xitter.gq/t.co/L0YQg8F2uW) finished accrual today @komop_tgkanker. Let us hope we can confirm these findings
The Oncologist Community retweeted
@FDAOncology Grants Priority Review to #Nivolumab + #Cabozantinib for Advanced 1L #RCC treatment based on Checkmate9ER which showed improvement in OS and doubling of PFS (16.6 vs 8.3 mo) & ORRs (55.7 vs 27.1%) vs. sunitinib @DrChoueiri onclive.com/view/fda-grants-…
The Oncologist Community retweeted
Very elegant work from @decarvalho_lab @Pari_Mehdipour here in @nature suggesting that combining epigenetic therapies with ADAR1 inhibitors could be a promising cancer treatment. Could this strategy revive epigenetic therapies?
nature.com/articles/s41586-0…
The Oncologist Community retweeted
We KNOW that the Geriatric Assessment is useful in oncology, AND guideline-recommended.
But are people actually using it❓
The @ASCO #gerionc taskforce conducted a global survey which is now published in @ASCO_pubs JCO-OP.
Check it out here 👇👇
ascopubs.org/doi/full/10.120…
The Oncologist Community retweeted
How radiation oncology is changing💡? 1.5 T MRlinac-guided SABR for isolated abdominal metastasis: check as never before radiation delivery on target 🎯 in high quality and in real time! #radonc #mrlinac #igrt #oligomets #adaptiveRT – at Verona, Veneto
The Oncologist Community retweeted
Spanish study finds higher mortality risk among myeloma patients hospitalized for COVID. @mvmateos #BCJ
Blood Cancer Journal
#WearAMask #StaySafe
nature.com/articles/s41408-0…
The Oncologist Community retweeted
Routine drains not necessary in liver surgery – same as for pancreatic surgery
Drain Placement After Uncomplicated Hepatic Resection Increases Severe Postoperative Complication Rate: A Japanese … pubmed.ncbi.nlm.nih.gov/3306…
The Oncologist Community retweeted
An important part of the informed consent process - outlining how long a “temporary stoma” may be temporary
New on Early View: Stoma reversal after intended restorative rectal cancer resection in Denmark: nationwide population‐based study ow.ly/wi4e30rdUVU
The Oncologist Community retweeted
If you are a top expert in your field, you have a tremendous power to uplift early career people with just a few words of encouragement. After my #ESMO20 talk, I received an email from Prof Fatima Cardoso congratulating me on my talk. It meant so much to me. Some thoughts 1/
The Oncologist Community retweeted
New precision therapy targeting DNA damage responses - @CD_AACR @AACR @royalmarsdenNHS @ICR_London
First-in-Human Trial of the Oral Ataxia Telangiectasia and Rad3-Related Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors cancerdiscovery.aacrjournals…








































